Navigation Links
United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
Date:4/18/2013

SILVER SPRING, Md., April 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2013 financial results before market open on Thursday, April 25, 2013.

United Therapeutics will host a half-hour teleconference on Thursday, April 25, 2013, at 9:00 a.m. Eastern Time.  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using conference code: 32040188.

This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm.  [uthr-g]

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.


'/>"/>
SOURCE United Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. National Honey Board Seeks Board Member Nominees: Appointments to be Made by United States Secretary of Agriculture
2. Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
3. Seven Outstanding Doctors Receive Honors From The United States & Canadian Academy of Pathology
4. United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
5. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
6. United Therapeutics Announces Additional $420 Million Share Repurchase Program
7. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
8. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
9. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
10. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
11. New Approach to Growing Waste to Value Industry in United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Veolia’s environmental monitoring technology division, Endetec, ... agreement with VWR to distribute TECTA™ B16, an ... 160 years of experience, VWR, a leading global ... production facilities, has cultivated a value proposition delivering ... enable science. Endetec’s TECTA™ B16, combines proven ...
(Date:5/20/2015)... , May 20, 2015 ... presented preliminary data demonstrating the ability of the ... fibrosis (IPF) from other interstitial lung diseases (ILDs) ... the classifier,s potential to help thousands of patients ... ambiguity in IPF diagnosis – a frequent challenge ...
(Date:5/20/2015)... This year has been one of the harshest ... Pearl’s Premium Ultra Low Maintenance Lawn Seed comes to ... coming out of record bad weather. Offering new ... concerns related to water, health, and climate change, Pearl's ... the standard, water-wasting, chemical-treated standard lawn. Many homeowners ...
(Date:5/20/2015)... 2015  Select Medical Corporation ("Select") (NYSE: ... granted early termination of the waiting period under ... as amended, applicable to the acquisition of Concentra ... venture that Select has created with Welsh, Carson, ... announced, MJ Acquisition Corporation has signed a definitive ...
Breaking Biology Technology:Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 2Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 3Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 4Veracyte Presents Preliminary Data Demonstrating Ability of Molecular Classifier to Improve Non-Surgical IPF Diagnosis Using Bronchoscopy Samples 5Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... ... Premier Biodefense Company; ... Expanded Biodefense Pipeline ANNAPOLIS, Md., and TEES VALLEY, England, March ... of medical,countermeasures against biological and chemical threats, and Avecia,Biologics Limited, a ...
... Simcere,Pharmaceutical Group (NYSE: SCR ), a leading ... the patented,anti-cancer biotech product Endu in China, today announces ... of Marketing and the promotion,of Baoxing Zha and Dasheng ... Sales respectively., The company also announces that Mr. ...
... ulcers each year in the US, PRINCETON, ... Board: DSCI), provider of advanced wound care products,announced ... the clinical usage,of its newly released MEDIHONEY(TM) Wound ... the annual American Professional Wound Care,Association (APWCA) conference ...
Cached Biology Technology:PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 2PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 3PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 4PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 5PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia 6Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions 2Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions 3Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 2Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 3Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 4
(Date:4/13/2015)... a leading cloud-based consumer engagement platform that provides trusted ... communities around health and wellness, announced today the launching ... The ... vehicle to receive validated health information from consumers. ... will allow higi,s trusted partners, on a user opt-in ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:4/6/2015)... Apr. 6, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... patent 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA ... NXT-ID introduces a new revolutionary method ... surrounds the use of miniature antenna modules for ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Nature Communications on January 22, 2013, a team of ... Museum of Los Angeles County,s (NHM) Dinosaur Institute, has discovered ... species. Confuciusornis sanctus , a 125-million-year-old Mesozoic ... almost body length ornamental tail feathers, others had none ...
... consuming more leaves and less fruit as a result ... to invest much more time foraging for sustenance and ... analysis., The research, published today in the International ... rainforests of the Mexican state of Veracruz, which are ...
... in vivo in mice, engage molecule CD98hc, which is involved ... skin,s capacity for regeneration. The results were published in ... epidermis, the surface layer of the skin, is mainly composed ... a 21-day cycle. These cells are located on a membrane ...
Cached Biology News:Sex of early birds suggests dinosaur reproductive style 2Monkeys stressed from longer foraging times 2Monkeys stressed from longer foraging times 3The skin aging regulator 2
Applications include ELISA, immunochemistry, and Western blotting. Working Concentrations: ELISA: 0.005-0.05 U/ml, immunohisto/cytochemistry: 0.25-0.5 U/ml, Western blot: 0.1-0.25 U/ml....
...
Recombinant Ovine IFN Tau. Active on sheep, cow, human and mouse cells. Activity: 5.7 x 10 7 u/mg...
... Thermo's Wellwash AC is the easiest ... and is provided with liquid level ... bottles. The integrated orbital shaker and ... excellent washing performance. The big bottle ...
Biology Products: